RSS

Clostridium difficile (C. difficile)

An affiliate of PureTech Health, Vedanta Biosciences, has been awarded a research grant of up to $5.4 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to support clinical testing of its lead product more

News